ENGOT > Discover > For Patients > Information about Clinical trials Information about Clinical trials The below overview shows links to information about open clinical trials accross the ENGOT Network. In case there are no relevant information or Group website available, we recommend to visit ClinicalTrials.gov or reach out to the individual ENGOT Groups directly. AGO (Germany) Expand For information about AGO trials in German, see here; in English, see here. A-AGO (Austria) Expand For information about A-AGO trials in German, see here. BGOG (Belgium and Luxembourg) Expand A BGOG trials website in development, for details, please reach out to BGOG Office at bgog@engot.eu or visit ClinicalTrials.gov. For an overview and information from Leuven Cancer Institute, Leuven (Belgium), see here. The website contains all trials that UZ Leuven is participating in, not only the ones from ENGOT. For more details you can reach out to lgog@uzleuven.be. CTI (Republic of Ireland) Expand For information about CTI trials, see here. CEEGOG (Czech Republic, Slovakia, Poland, Slovenia, Hungary, Belarus, Ukraine, Georgia, Croatia, Macedonia, Serbia, Romania, Republic of Moldova) Expand For overview of CEEGOG trials, please see here. DGOG (the Netherlands) Expand For overview of DGOG open trials, see here; for closed trials, see here. EORTC GCG (the Netherlands, Belgium, France) Expand An overview website not developed, for any additional information, please visit ClinicalTrials.gov or see here. GEICO (Spain) Expand Information to be updated, in the meantime visit ClinicalTrials.gov. GINECO (France) Expand For a general overview of GINECO trials, see here; more detailed website is in development, you can also visit ClinicalTrials.gov. GTG-UK (United Kingdom) Expand Detailed overview website of GTG-UK trials in development, please see below sources available in the UK, or visit ClinicalTrials.gov. For information about trials in the UK, please see: Cancer Research UK and nurses helpline freephone 0808 800 4040; Target Ovarian Cancer ; ctc.ucl.ac.uk/ForPatients ctc.ucl.ac.uk/Trials icr.ac.uk HeCOG (Greece) Expand For information about HeCOG trials, see here or visit ClinicalTrials.gov. IGSO (Israel) Expand The ISGO overview website currently under development. Please contact leoramcc@gmail.com or visit ClinicalTrials.gov. MaNGO (Italy) Expand For overview of MaNGO trials, visit here. MITO (Italy) Expand For overview of MITO trials, visit here. NOGGO (Germany) Expand For overview of NOGGO trials visit here - Please note that this page is primarily intended for medical professionals. The study descriptions are kept quite brief, as in Germany all public study information must be approved by an ethics committee. For this reason, visit ClinicalTrials.gov for more detailed information. NOGGO trials also listed on: Gyn-Onc Studies Ovarian Cancer Endometrial Cancer Cervical Cancer Gynecological Sarcoma Breast Cancer NSGO-CTU (Denmark, Finland, Norway, Sweden, Estonia, Lithuania) Expand For overview of NSGO-CTU trials, see here. PGOG (Poland) Expand For overview of PGOG trials, see here. SAKK (Switzerland) Expand For overview of SAKK trials, see here. SGCTG (United Kingdom - Scotland) Expand Please see below sources available in the UK, or visit ClinicalTrials.gov. For information about trials in the UK, please see: Cancer Research UK and nurses helpline freephone 0808 800 4040; Target Ovarian Cancer ; ctc.ucl.ac.uk/ForPatients ctc.ucl.ac.uk/Trials icr.ac.uk Swiss-GO (Switzerland) Expand For overview of Swiss-GO trials, see here. TRSGO (Turkey) Expand Overview website not available, for any relevant information please visit ClinicalTrials.gov. Next ENGOT Meeting September 18-19, 2025 Bergamo, Italy Directly to: ESGO Annual Congress ESGO‘s Journal latest articles myESGO ENGOT Newsletter Get notified on all ENGOT news and activities right in your mailbox. Sign-up Now! You May Also Like GCA WORKSHOPSWatch the Webcasts Read More CLINICAL TRIALSLatest Published Research Read More FOR PATIENTSKey Insights Read More ESGO 2026February 26-28, 2026 Copenhagen, Denmark Read More